Barinthus Biotherapeutics PLC - ADR

NEW
STU:2AB (USA)   ADR
€ 0.49 +0.0060 (+1.23%) Aug 14
At Loss
P/B:
0.42
Market Cap:
€ 20.18M ($ 23.34M)
Enterprise V:
€ -22.13M ($ -25.60M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Barinthus Biotherapeutics PLC (STU:2AB) Dividend

Barinthus Biotherapeutics PLC (STU:2AB) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.7%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:2AB Dividend

Does Barinthus Biotherapeutics PLC (STU:2AB) pay a dividend?

Barinthus Biotherapeutics PLC (STU:2AB) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Barinthus Biotherapeutics PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Barinthus Biotherapeutics PLC has returned capital to shareholders via buybacks at a rate of -2.7% over the past 3 years.

What are dividend-paying alternatives to Barinthus Biotherapeutics PLC?

For dividend-paying alternatives in Barinthus Biotherapeutics PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.